April 11 (Reuters) - Conduit Pharmaceuticals Inc CDT.O:
CONDUIT PHARMACEUTICALS ANNOUNCES NOVEL COCRYSTAL PATENT FILING FOR VTAMA® (TAPINAROF) WITH ENHANCED THERAPEUTIC AND MARKET EXTENSION PROSPECTS
Source text: ID:nGNX3dZ2TK
Further company coverage: CDT.O
((Reuters.Briefs@thomsonreuters.com;))